Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry.
Sanjeeb BhandariPierre-Henry GabrielleVuong NguyenVincent DaienFrancesco ViolaWalid BougamhaStephanie YoungBarbara Romero-NuñezMarc Figueras-RocaJavier Zarranz-VenturaDaniel BarthelmesLaura SararolsMark GilliesCatherine Creuzot-GarcherPublished in: Ophthalmology and therapy (2022)
One-year treatment outcomes of dexamethasone intravitreal implant for DMO in routine clinical practice were inferior to those in the clinical trials perhaps because of fewer treatments in clinical practice.